Lanean...
“A Growth Model of Neuroendocrine Tumor Surrogates and the Efficacy of a Novel Somatostatin-Receptor Guided Antibody-Drug Conjugate: Perspectives on Clinical Response?”
BACKGROUND: As patient-derived xenografts (PDXs) and other preclinical models of neuroendocrine tumors (NETs) for testing personalized therapeutics are lacking, we have developed a perfused 3D bioreactor model to culture tumor surrogates from patient-derived NETs. This work evaluates the duration of...
Gorde:
| Argitaratua izan da: | Surgery |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8162105/ https://ncbi.nlm.nih.gov/pubmed/31543319 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.surg.2019.04.073 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|